Agrylin
FDA Approves Octaplas to Treat Blood Clotting Disorders »
"The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels. Clotting pr"...
Read the FDA Approves Octaplas to Treat Blood Clotting Disorders article »
Agrylin
PATIENT INFORMATION
No information provided. Please refer to the WARNINGS and PRECAUTIONS sections.
Last reviewed on RxList: 12/16/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Agrylin Information
Agrylin - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.






